Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-26

Clinical Trial Update: Safety of Fondaparinux as Post Partum Thromboprophylaxis [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing the safety of fondaparinux for postpartum thromboprophylaxis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fondaparinux (fondaparinux)

Snippet

Sponsor: National University of Malaysia | Conditions: Thromboembolism in the Puerperium | Phase 4 | Status: COMPLETED